Search clinical trials for: Seliciclib

Total 7 results

University Hospital, Brest
Cyclacel Pharmaceuticals, Inc.; ManRos Therapeutics

Terminated

Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation (ROSCO-CF)

Cystic Fibrosis

France
Cyclacel Pharmaceuticals, Inc.

Terminated

Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Cedars-Sinai Medical Center

Recruiting

Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

Cushing Disease

United States
Shlomo Melmed, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Treatment of Cushing's Disease With R-roscovitine

Cushings Disease

United States
Cyclacel Pharmaceuticals, Inc.

Completed

A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
M.D. Anderson Cancer Center
National Institutes of Health (NIH)

Withdrawn

Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Breast Cancer
Engelhard Arzneimittel GmbH & Co.KG
ClinCompetence Cologne GmbH

Completed

Sinolpan® Pharmacy Non-interventional Study - Quality of Live

Bronchitis | Rhinosinusitis Chronic | Rhinosinusitis Acute

Germany

3

Subscribe